Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Dec 02, 2020 8:54pm
302 Views
Post# 32023594

RE:6 sedar reports

RE:6 sedar reportsActually SeDI reports not SEDAR
The SEDI reports are for insider buying. They utilized thier Dec share rights and bought on the open market about 3000 shares each.
Not huge, but that is the number based on thier year end "share purchse optoins"
They could & did , yesterday...
Not sure why it says "6 reports  issued" as it only seemed to be one.
Unless there are Sedar reports filed at same time?coincidence.
anyhow, insiders are buying.
Save the "not a large amount line" I get that. They bought what thier employment contract allowed.
The most recent B.D  ( bernard..something) dr has the most shares BTW 229,000 shars.
He has only been with oNC a short time & is buying like crazy.

<< Previous
Bullboard Posts
Next >>